The Everolimus-Transplant Exit Strategy Trial (E-TEST)
This study is not yet open for participant recruitment.
Verified November 2012 by Emory University
Sponsor:
Allan D Kirk, MD, PhD
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Allan D Kirk, MD, PhD, Emory University
ClinicalTrials.gov Identifier:
NCT01636466
First received: July 5, 2012
Last updated: November 5, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | January 2017 |
| Estimated Primary Completion Date: | January 2016 (Final data collection date for primary outcome measure) |